Ken Frazier Promoted at Merck for Nonlegal Post
New Jersey-based Merck took Kenneth C. Frazier out of the company’s general counsel spot and put him into the role of executive vice president and president of the global human health department, effective Aug. 1.
He will oversee more than 30,000 employees and have direct responsibility for Merck’s marketing and sales organizations worldwide including the global pharmaceutical and vaccine franchises.
Frazier, 52, had served as general counsel since 1999 and had been with the company since 1992. Prior to that, he was a partner at Drinker Biddle & Reath.
Bruce N. Kuhlik, who is being promoted to senior vice president, will succeed Frazier as general counsel with responsibility for Merck’s legal and public affairs functions.
Kuhlik, 50, joined Merck in 2005 as vice president and associate general counsel with primary responsibility for the company’s Vioxx litigation defense. Frazier will continue to assist Kuhlik on the Vioxx litigation.
Prior to joining Merck, Kuhlik was the general counsel for the Pharmaceutical Research and Manufacturers of America and was an attorney with Washington, D.C.-based Covington & Burling.Explore posts in the same categories: Firm News